MAYBAKER Stock Overview
May & Baker Nigeria Plc manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 2/6 |
Financial Health | 5/6 |
Dividends | 2/6 |
Rewards
Risk Analysis
May & Baker Nigeria plc Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₦5.10 |
52 Week High | ₦8.50 |
52 Week Low | ₦3.90 |
Beta | 0.0088 |
1 Month Change | -20.93% |
3 Month Change | 0.99% |
1 Year Change | 13.33% |
3 Year Change | 30.77% |
5 Year Change | 112.50% |
Change since IPO | 280.80% |
Recent News & Updates
Recent updates
Shareholder Returns
MAYBAKER | NG Pharmaceuticals | NG Market | |
---|---|---|---|
7D | -5.9% | 2.1% | 2.2% |
1Y | 13.3% | 11.8% | 128.1% |
Return vs Industry: MAYBAKER exceeded the NG Pharmaceuticals industry which returned 11.8% over the past year.
Return vs Market: MAYBAKER underperformed the NG Market which returned 128.1% over the past year.
Price Volatility
MAYBAKER volatility | |
---|---|
MAYBAKER Average Weekly Movement | 13.2% |
Pharmaceuticals Industry Average Movement | 4.6% |
Market Average Movement | 9.0% |
10% most volatile stocks in NG Market | 12.6% |
10% least volatile stocks in NG Market | 4.3% |
Stable Share Price: MAYBAKER's share price has been volatile over the past 3 months.
Volatility Over Time: MAYBAKER's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of NG stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1944 | 364 | Patrick Ajah | https://www.may-baker.com |
May & Baker Nigeria Plc manufactures, sells, and distributes human pharmaceuticals, human vaccines, and consumer products in Nigeria. The company offers pharmaceuticals, including anti-diabetic, anti-hypersensitive, anti-infective, anti-malaria, analgesic, cough and cold, and anxiolytics; and nature care products. It also provides beverage drinks, including bottled water under the Lily Water name; and hand and surface sanitizers under the Smartans name.
May & Baker Nigeria plc Fundamentals Summary
MAYBAKER fundamental statistics | |
---|---|
Market cap | ₦8.80b |
Earnings (TTM) | ₦985.57m |
Revenue (TTM) | ₦19.70b |
8.9x
P/E Ratio0.4x
P/S RatioIs MAYBAKER overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MAYBAKER income statement (TTM) | |
---|---|
Revenue | ₦19.70b |
Cost of Revenue | ₦13.12b |
Gross Profit | ₦6.58b |
Other Expenses | ₦5.59b |
Earnings | ₦985.57m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 0.57 |
Gross Margin | 33.41% |
Net Profit Margin | 5.00% |
Debt/Equity Ratio | 76.9% |
How did MAYBAKER perform over the long term?
See historical performance and comparison